Lagoon edit · Free shipping over $80 · Glass-clear summer drops
Login Register
Description

KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)

PRINCIPIO ACTIVO: EBERCONAZOL

diseñado para mejorar la absorción y facilitar el ajuste preciso de la dosis en pacientes que requieren tratamiento prolongado

300 ML Aerosol

Caja con 1 jeringa precargada de 40 mg/0

TRILEPTAL 60MG 1ML SUSP 100ML OTCLABORATORIOS SANFER SA DE C KADCYLA® 160 mg es unPRINCIPIO ACTIVO: OXCARBAMAZEPINA

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products